Xiamen Biotime Biotechnology is one of the fastest growing diagnostic healthcare manufacturers serving to enhance the health and well-being of people around the world through the development of diagnostic solutions that is supported by our combined strength in long-term R&D and manufacturing productivity. With headquarter in Xiamen Special Economic Zone, we serve customers around the world with innovative medical devices, diagnostics. Our 3000+ colleagues are working diligently to make the organisation become more responsive and accountable to industry. Biotime has been committed to pushing forward technological innovation and is an owner of 50+ patents. We offer accurate, reliabe and cost-effective in vitro diagnostics solutions, covering colloidal gold, fluorescence immunochromatography, high-performance liquid chromatography, mass spectrometry, electro-chemistry, light-induced chemiluminescence, coagulation, Raman, molecular POCT and some other technologies in precision diagnosis. We’ve never been afraid to be the first mover. In fact we have introduced 10 different types of product that were first-of-their-kind at the time they were brought into China market. Research and development has never been more important for us, and our substainial investment in R&D reflects that. Today, Biotime’s R&D team comprises dozens of doctoral researchers and ever so many highly accomplished individuals who have, or can develop, the necessary skills and knowledge for the research in hand. The research team from Biotime is working with Northwest University, Sandford-Burham Medical Research Institute, Xiamen University, Third Institute of Oceanography and MNR, focused on innovative research around rapid diagnostics and POCT technology. We also have an effective management team which brings together a diversity of talent and a wealth of experience.